Glabridin

Description: Glabridin (KB-289522) may serve as an anti-inflammatory agent in diabetes-related vascular dysfunction, through regulating the synthesis and activity of iNOS under high-glucose levels, may possess a therapeutic effect on metabolic disorders( such as diabetes and hyperglycemia), by modulating glucose metabolism through AMPK in skeletal muscle cells. Glabridin may have potential as a chemopreventive agent against liver Y metastasis, by inhibiting the invasion of human HCC cells. Target: Antibacterial, Tyrosinase, GABA Receptor, Reactive Oxygen Species, PPAR. Smiles: CC1(C)Oc2ccc3C[C@@H](COc3c2C=C1)c1ccc(O)cc1O. References: Yokota Tm , et al. Pigment Cell Res. 1998 Dec,11(6):355-61.